Interferon Gamma , Bex , and Covid ?11 Dec 2021 10:36
Doing some digging on Interferon Gamma , and some interesting info is popping up .
IFN Gamma definitely seems to play a part in tumour immunity , although studies are still trying to figure out the whole picture . Success has been seen in some cancers , but not all , and some data seems totally contradictory .
This study stood out however
https://www.frontiersin.org/articles/10.3389/fimmu.2020.585647/full
Only done last year , so still a recent discovery - as to do with Covid symptoms .
They seem to make a connection with patients having more lung fibrosis after recovering from Covid , if their IFN Gamma levels were low .
They conclude if you were to administer IFN G (or a drug that raised IFN Gamma levels , see where I'm going with this ? ) at an early stage - then that could possibly be a benefit .
According to the BMJ , 72% of severe Covid patients who need mechanical ventilation - show lung fibrosis 4 months after hospitalisation . Pulmonary fibrosis seems to be one of the worst effects of long covid , for those who had it bad . It even showed up in 20% of those hospitalised patients who weren't on ventilation .
From this weeks RNS :
The biomarker analysis shows that in patients receiving treatment with bexmarilimab, interferon gamma levels increased after the first dose. Interferon gamma is a marker for inflammation which suggests bexmarilimab may amplify an immune response.
Have we inadvertently also found a treatment for Covid / Pulmonary Fibrosis ?
Lets hope they've got some patents submitted !
Considering they've done the TLR9 Agonist patent ( something we haven't heard about yet ) , who knows .
I could be barking up the wrong tree completely , but it's fun to speculate .